EHHADH deficiency regulates pexophagy and accelerates tubulointerstitial injury in diabetic kidney disease

Shuyan Kan,Qing Hou,Jinsong Shi,Mingchao Zhang,Feng Xu,Zhihong Liu,Song Jiang

DOI: https://doi.org/10.1038/s41420-024-02066-4

2024-06-16

Cell Death Discovery

Abstract:Peroxisomal l -bifunctional enzyme (EHHADH) plays a role in the classic peroxisomal fatty acid β-oxidation pathway; however, the relationship between EHHADH expression and diabetic kidney disease has not been well understood. Here, we found that endogenous EHHADH levels were strongly correlated with the progression and severity of diabetic nephropathy in T2D patients. EHHADH knockout mice exhibited worsened renal tubular injury in diabetic mice. Furthermore, EHHADH is a modulator of pexophagy. In renal tubular epithelial cells (RTECs) in vitro, the knockdown of EHHADH induced a dramatic loss of peroxisomes. The loss of peroxisomes in EHHADH-deficient RTECs was restored by either an autophagic inhibitor 3-methyladenine or bafilomycin A1 both in vitro and in vivo. NBR1 was required for pexophagy in EHHADH-knockdown cells, where the level of reactive oxygen species (ROS) was increased, while inhibition of ROS blocked pexophagy. In summary, our findings revealed EHHADH deficiency accelerated renal injury in DKD as a modulator of pexophagy.

cell biology

What problem does this paper attempt to address?

The problem this paper attempts to address is the role and mechanism of EHHADH (enoyl-CoA hydratase and 3-hydroxyacyl-CoA dehydrogenase) in diabetic kidney disease (DKD). Specifically, researchers found that the expression of EHHADH is closely related to the progression and severity of diabetic kidney disease in patients with type 2 diabetes (T2D), and EHHADH knockout mice exhibit more severe tubular injury under diabetic conditions. Additionally, the study revealed the role of EHHADH as a regulator of selective autophagy (pexophagy), where the lack of EHHADH induces pexophagy by increasing reactive oxygen species (ROS) levels, leading to peroxisome loss and thereby accelerating kidney injury in diabetic kidney disease.

### Main Research Content:
1. **Relationship between EHHADH expression and diabetic kidney disease**: Through gene expression profiling, researchers found that the expression of EHHADH is related to the progression of tubular interstitial injury in patients with diabetic kidney disease.
2. **Impact of EHHADH knockout on diabetic kidney disease**: By constructing an EHHADH knockout mouse model, researchers found that EHHADH knockout mice exhibit more severe tubular injury, increased proteinuria, and decreased renal function under diabetic conditions.
3. **Impact of EHHADH deficiency on peroxisomes**: EHHADH knockdown leads to the loss of peroxisomes in renal tubular epithelial cells (RTECs), which can be restored by inhibiting autophagy.
4. **Relationship between EHHADH deficiency and pexophagy**: The study found that EHHADH deficiency promotes pexophagy by increasing ROS levels, leading to the degradation of peroxisomes.
5. **Role of NBR1 in EHHADH-mediated pexophagy**: NBR1, as an important autophagy receptor, is involved in the regulation of pexophagy in EHHADH knockdown cells.

### Conclusion:
This study reveals the important role of EHHADH in diabetic kidney disease, particularly its mechanism of influencing tubular injury by regulating pexophagy. These findings provide new potential targets for the treatment of diabetic kidney disease.